Is the era of prostatic specific antigen over?

被引：2
作者：
Morote-Robles, Juan [1 ]
机构：
[1] Univ Autonoma Barcelona, Serv Urol, Hosp Gen Valle Hebron, Barcelona 08025, Spain
来源：
MEDICINA CLINICA | 2006年 / 126卷 / 15期
关键词：
D O I：
10.1157/13087700
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：579 / 580
页数：2
相关论文
共 22 条
  • [1] Screening for prostate cancer: have you had your cholesterol measured?
    Boyle, P
    [J]. BJU INTERNATIONAL, 2003, 92 (03) : 191 - 199
  • [2] Serum PSA correlates more strongly with percentage of cancer and cancer volume than with prostate size
    Catalona, WJ
    Yu, XY
    Roehl, KA
    Yeh, JT
    Gashti, SN
    Antenor, JAV
    Han, M
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04) : 257 - 257
  • [3] The PSA era is not over for prostate cancer
    Catalona, WJ
    Loeb, S
    [J]. EUROPEAN UROLOGY, 2005, 48 (04) : 541 - 545
  • [4] COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE-SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE-CANCER - RESULTS OF A MULTICENTER CLINICAL-TRIAL OF 6,630 MEN
    CATALONA, WJ
    RICHIE, JP
    AHMANN, FR
    HUDSON, MA
    SCARDINO, PT
    FLANIGAN, RC
    DEKERNION, JB
    RATLIFF, TL
    KAVOUSSI, LR
    DALKIN, BL
    WATERS, WB
    MACFARLANE, MT
    SOUTHWICK, PC
    [J]. JOURNAL OF UROLOGY, 1994, 151 (05) : 1283 - 1290
  • [5] uPM3, a new molecular urine test for the detection of prostate cancer
    Fradet, YF
    Saad, F
    Aprikian, A
    Dessureault, J
    Elhilali, M
    Trudel, C
    Måsse, B
    Piché, L
    Chypre, C
    [J]. UROLOGY, 2004, 64 (02) : 311 - 315
  • [6] DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer
    Hessels, D
    Gunnewiek, JMTK
    van Oort, I
    Karthaus, HFM
    van Leenders, GJL
    van Balken, B
    Kiemeney, LA
    Witjes, JA
    Schalken, JA
    [J]. EUROPEAN UROLOGY, 2003, 44 (01) : 8 - 15
  • [7] Hessels D., 2005, EAU UPDATE SER, V3, P200, DOI DOI 10.1016/J.EUUS.2005.09.005
  • [8] Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%
    Khan, MA
    Sokoll, LJ
    Chan, DW
    Mangold, LA
    Mohr, P
    Mikolajczyk, SD
    Linton, HJ
    Evans, CL
    Rittenhouse, HG
    Partin, AW
    [J]. UROLOGY, 2004, 64 (06) : 1160 - 1164
  • [9] A multicenter clinical trial on the use of (-5-7) pro prostate specific antigen
    Lein, M
    Semjonow, A
    Graefen, M
    Kwiatkowski, M
    Abramjuk, C
    Stephan, C
    Haese, A
    Chun, F
    Schnorr, D
    Loening, SA
    Jung, K
    [J]. JOURNAL OF UROLOGY, 2005, 174 (06) : 2150 - 2153
  • [10] Are multiple markers the future of prostate cancer diagnostics?
    Mikolajczyk, SD
    Song, Y
    Wong, JR
    Matson, RS
    Rittenhouse, HG
    [J]. CLINICAL BIOCHEMISTRY, 2004, 37 (07) : 519 - 528
123